The Imaging Dementia — Evidence for Amyloid Scanning (IDEAS) Study will establish an open-label, longitudinal cohort study to assess the impact of amyloid PET on patient outcomes under Coverage with Evidence (CED) in patients meeting appropriate use criteria (AUC) for amyloid PET.
The purpose of this research study is to examine how brain imaging helps guide a physician in how to treat a patient’s condition, and whether these changes in treatment lead to better medical outcomes. Increased amyloid plaques in the brain have been linked with Alzheimer’s disease and related brain disorders. The study is being run by experienced researchers, the Alzheimer’s Association, and the American College of Radiology Imaging Network (ACRIN). The research component is to study if the brain imaging will help your physician treat a patient and benefit patients; the brain imaging itself is not part of the research, but a procedure recommended by your doctor as part of clinical care.
The study is including patients who are 65 years and older with diagnosed Alzheimer’s, dementia, mild cognitive impairment.
Kim Glorieux, CRC: 425.635.6082, Kimberly.Glorieux@overlakehospital.org
Tina Fortney, RN, BSN, CCRC: 425.688.5407, Tina.Fortney@overlakehospital.org